» Articles » PMID: 33093908

Clinical and Molecular Findings in a Family Expressing a Novel Heterozygous Variant of the G Elongation Factor Mitochondrial 1 Gene

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2020 Oct 23
PMID 33093908
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

The identified mutations in the G elongation factor mitochondrial 1 (GFM1) gene have been associated with heterogeneous clinical features of an early-onset mitochondrial disease in only 25 families. The present study reports the case of two siblings with a novel GFM1 variant and their clinical and laboratory presentations, which included progressive hepatic encephalopathy, failure to thrive and persistent lactic acidemia. Both histological changes and diminished expression of the GFM1 protein were observed in the liver and kidney tissues of the index patient. Whole-exome and Sanger sequencing technologies were used to diagnose the index patient with defective GFM1 using amniocentesis at 32 weeks' gestation. Heterozygous mutations in the GFM1 gene were identified in both siblings: A novel mutation, C1576T in exon 13 inherited from their asymptomatic mother, resulting in a premature stop codon at amino acid position 526 and the previously reported G688A mutation on the boundary between exon 5 and intron 5-6, inherited from their asymptomatic father. In conclusion, the present study reports two siblings carrying a novel GFM1 variant with a rare fatal mitochondrial disease.

Citing Articles

Molecular pathways in mitochondrial disorders due to a defective mitochondrial protein synthesis.

Antolinez-Fernandez A, Esteban-Ramos P, Fernandez-Moreno M, Clemente P Front Cell Dev Biol. 2024; 12:1410245.

PMID: 38855161 PMC: 11157125. DOI: 10.3389/fcell.2024.1410245.


Mitochondrial Protein Translation: Emerging Roles and Clinical Significance in Disease.

Wang F, Zhang D, Zhang D, Li P, Gao Y Front Cell Dev Biol. 2021; 9:675465.

PMID: 34277617 PMC: 8280776. DOI: 10.3389/fcell.2021.675465.

References
1.
Barcia G, Rio M, Assouline Z, Zangarelli C, Gueguen N, Dumas V . Clinical, neuroimaging and biochemical findings in patients and patient fibroblasts expressing ten novel GFM1 mutations. Hum Mutat. 2019; 41(2):397-402. DOI: 10.1002/humu.23937. View

2.
Antonicka H, Sasarman F, Kennaway N, Shoubridge E . The molecular basis for tissue specificity of the oxidative phosphorylation deficiencies in patients with mutations in the mitochondrial translation factor EFG1. Hum Mol Genet. 2006; 15(11):1835-46. DOI: 10.1093/hmg/ddl106. View

3.
Valente L, Tiranti V, Marsano R, Malfatti E, Fernandez-Vizarra E, Donnini C . Infantile encephalopathy and defective mitochondrial DNA translation in patients with mutations of mitochondrial elongation factors EFG1 and EFTu. Am J Hum Genet. 2006; 80(1):44-58. PMC: 1785320. DOI: 10.1086/510559. View

4.
Sergiev P, Bogdanov A, Dontsova O . How can elongation factors EF-G and EF-Tu discriminate the functional state of the ribosome using the same binding site?. FEBS Lett. 2005; 579(25):5439-42. DOI: 10.1016/j.febslet.2005.09.010. View

5.
Christian B, Spremulli L . Mechanism of protein biosynthesis in mammalian mitochondria. Biochim Biophys Acta. 2011; 1819(9-10):1035-54. PMC: 3314146. DOI: 10.1016/j.bbagrm.2011.11.009. View